NeuroSigma, Inc.
LOS ANGELES, CA · Founded 2008 · CIK 0001494756 · Medtech · Private
Thin Film Nitinol Micromesh carotid stent (DELTA stent) for preventing stroke during carotid artery revascularization
neurosigma.com →- Grants
- $5.2M
- 4 awards
- Sector median: 1
- Raised
- $13M
- 3 Form D · Aug 2016
- 121 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 35
- 8 granted · 27 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓200920112013201520172019
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $450,000 | |
| Private capital raised | Form D · SEC | $500,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms | $2,949,208 | |
| Private capital raised | Form D · SEC | $11,653,514 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms | $899,775 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Testing of a Novel Flow Diverting Stent for Treating Intracranial Aneurysms | $976,739 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of an Anti-Embolic Micromesh Carotid Stent | $415,743 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 927 | Alexza Pharmaceuticals Inc. | — | $37M |
| 928 | APO Technologies, Inc | — | — |
| 929 | Telcare, Inc. | — | $65M |
| 930 | NeuroSigma, Inc. | — | $13M |
| 931 | CymoGen Dx, LLC | — | $350K |
| 932 | ADVANCED BIODEVICES LLC | — | — |
| 933 | VENTRIX INCORPORATED | — | $5.2M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Kirk CalhounDirector
- Lodwrick CookDirector
- Leon EkchianDirector · Executive Officer
- James HindmanDirector
Patents
- Pulse Generator For Trigeminal Nerve Stimulationapplication
- Pulse Generator For Trigeminal Nerve Stimulationapplication
- Extracranial Implantable Devices, Systems And Methods For The Treatment Of Neurological Disordersapplication
- Trigeminal Neurostimulation Based Upon Pulse Counting And Chronobiologygranted
- Cutaneous Electrodegranted
- Extracranial Implantable Devices, Systems And Methods For The Treatment Of Neurological Disordersapplication
- Extracranial Implantable Devices, Systems And Methods For The Treatment Of Neuropsychiatric Disordersgranted
- Subcutaneous Electrodes For Cranial Nerve Stimulationgranted
- Pulse Generator For Cranial Nerve Stimulationgranted
- Modulation Of Autonomic Nervous System Activity And Integrated Electrode Assemblies For Trigeminal Neurostimulationapplication
- Modulation of Autonomic Nervous System Activity and Integrated Electrode Assemblies for Trigeminal Neurostimulationgranted
- Template For Trigeminal Neurostimulationapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.